India's benchmark indexes are likely to open little changed on Tuesday, after logging their best day in more than four years ...

(Reuters) -Indian pharma stocks fell 1.6% on Monday, bucking broader market gains, after U.S. President Trump said he would ...

Pharma stocks rise amid market drop due to limited impact from US pricing order. Discover more on what fuels this trend.

Pharma stocks lit up Dalal Street on Tuesday as President Donald Trumps remarks on drug pricing sent mixed signals to global ...

Indian pharmaceutical shares dropped up to 7% following US President Donald Trump's pledge to significantly lower US drug ...

India's GlaxoSmithKline Pharmaceuticals reported a higher fourth-quarter profit on Tuesday, led by steady demand for its ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your trusted source for real-time updates and thorough analysis of a ...

US President Trump's move to cut drug prices by 30–80% may severely impact Indian pharma exports and profitability, ...

Pharma stocks faced a downturn after US President Donald Trump revealed plans to slash drug prices. Sun Pharmaceuticals and ...

Trump said he would introduce a “most favoured nation” (MFN) policy whereby the US pays “the same price as the nation that ...

Shares of Indian pharmaceutical companies fell up to 7% after US President Donald Trump promised to sign an executive order ...

By linking US drug prices to those paid in similar economies, order could alter how pharmaceutical companies price their ...